FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes. Pant S. JAMA 2025 Nov 7. doi: 10.1001/jama.2025.19724.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pant S. FDA Approves GLP-1 Pill for Cardiovascular Risk in Type 2 Diabetes. JAMA 2025 Nov 7. doi: 10.1001/jama.2025.19724.
PMID: 41201832